RPS6KB1 and cancer: In another study, rapamycin, an mTOR inhibitor, affects the downstream inactivation of S6K1 and 4E-BP1 by inhibiting phosphorylation, which decreases protein synthesis and cell cycle arrest in the G1 phase and suppresses the growth of various cancer cell lines [58].